Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Keating

Showing results (681-690 of 963) with videos related to

Pageof 97
Sort By:
American Journal of Clinical Pathology|November 9, 2000
11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analysesS Ibrahim, E H Estey, S Pierce, et al.
The American Journal of Medicine|January 1, 1993
Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosisP M Derderian, H M Kantarjian, M Talpaz, et al.
Clinical Orthopaedics and Related Research|July 14, 2001
Long-term followup of anatomic graduated components posterior cruciate-retaining total knee replacementM A Ritter, M E Berend, J B Meding, et al.
Leukemia|January 17, 2003
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNAI Jilani, E Estey, T Manshuri, et al.
Blood|January 7, 1998
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to workM de Lima, S S Strom, M Keating, et al.
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.
Wellcome Open Research|July 7, 2022
cellmlmanip and chaste_codegen: automatic CellML to C++ code generation with fixes for singularities and automatically generated JacobiansMaurice Hendrix, Michael Clerx, Asif U Tamuri, et al.
The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.
The American Journal of Medicine|April 29, 1998
Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemiaM DeLima, M Albitar, S O'Brien, et al.
Clinical Orthopaedics and Related Research|January 12, 2001
The clinical significance of vacuum mixing bone cementM H Geiger, E M Keating, M A Ritter, et al.
Pageof 97

Showing results (681-690 of 963) with videos related to

Sort By:
Pageof 97
American Journal of Clinical Pathology|November 9, 2000
11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analysesS Ibrahim, E H Estey, S Pierce, et al.
The American Journal of Medicine|January 1, 1993
Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosisP M Derderian, H M Kantarjian, M Talpaz, et al.
Clinical Orthopaedics and Related Research|July 14, 2001
Long-term followup of anatomic graduated components posterior cruciate-retaining total knee replacementM A Ritter, M E Berend, J B Meding, et al.
Leukemia|January 17, 2003
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNAI Jilani, E Estey, T Manshuri, et al.
Blood|January 7, 1998
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to workM de Lima, S S Strom, M Keating, et al.
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.
Wellcome Open Research|July 7, 2022
cellmlmanip and chaste_codegen: automatic CellML to C++ code generation with fixes for singularities and automatically generated JacobiansMaurice Hendrix, Michael Clerx, Asif U Tamuri, et al.
The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.
The American Journal of Medicine|April 29, 1998
Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemiaM DeLima, M Albitar, S O'Brien, et al.
Clinical Orthopaedics and Related Research|January 12, 2001
The clinical significance of vacuum mixing bone cementM H Geiger, E M Keating, M A Ritter, et al.
Pageof 97